Synergistic effect of malathion and estrogen on mammary gland carcinogenesis

Calaf,Gloria  M.; Echiburú-Chau,Carlos

doi:10.3892/or.2012.1817

Synergistic effect of malathion and estrogen on mammary gland carcinogenesis

Authors:
- Gloria M. Calaf
- Carlos Echiburú-Chau
View Affiliations

Affiliations: Institute for Advanced Research, Tarapacá University, Arica, Chile, Center for Radiological Research, Columbia University Medical Center, New York, NY, USA
Published online on: May 17, 2012 https://doi.org/10.3892/or.2012.1817
Pages: 640-646

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer is the most frequent malignancy diagnosed in women and is a classical model of hormone-dependent malignancy. Over the past 15-20 years, epidemiological studies have pointed to an increased breast cancer risk associated with prolonged exposure to female hormones. On the other hand, environmental chemicals such as malathion, an organophosphorous pesticide used to control a wide range of sucking and chewing pests of field crops, may be involved in the etiology of breast cancers. Results indicated that estrogen alone increased average number of lobules per mm2 of rat mammary glands in comparison to control and malathion alone at 30, 124, 240 and 400 days after 5-day treatments. On the other hand, malathion alone significantly increased the number of ducts in stage of proliferation at 10-240 days after 5-day treatments. Furthermore, markers for cancer detection such as mutant p53, c-myc, c-fos and CYPs proteins were overexpressed after treatments. Atropine, an anticholinergic drug, counteracted these effects when it was combined with malathion under similar conditions. The combination of malathion and estrogen synergistically increased number of lobules and ducts per mm2 of rat mammary glands after treatments and inducing mammary cancer. It can be concluded that combination of an environmental substance such as the pesticide malathion and an endogenous substance such as estrogen can enhance the deleterious effects in human mammary glands inducing cancer and atropine is able to diminish these effects.

View Figures

View References

1	Dickson RB, Gelmann EP, Knabbe C, et al: Mechanisms of estrogenic and antiestrogenic regulation of growth of human breast carcinoma. Hormonal Manipulation of Cancer: Peptides, Growth Factors, and New (Anti) Steroidal Agents. Klijn JGM: Raven Press; New York, NY: pp. 381–403. 1987
2	Clark GM and McGuire WL: Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol. 18:20–25. 1989.
3	Clarke RB, Howell A, Potten CS, et al: Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57:4987–4991. 1997.PubMed/NCBI
4	Henderson BE, Pike MC and Ross RK: Epidemiology and risk factors. Breast Cancer: Diagnosis and Management. Bonadonna G: John Wiley and Sons Ltd; New York, NY: pp. 1–17. 1984
5	Henderson BE, Ross RK and Pike MC: Hormonal chemoprevention of cancer in women. Science. 259:633–638. 1993. View Article : Google Scholar : PubMed/NCBI
6	Perera FP: Environment and cancer: who are susceptible? Science. 278:1068–1073. 1997. View Article : Google Scholar : PubMed/NCBI
7	McLachlan JA: Functional toxicology: a new approach to detect biologically active xenobiotics. Environ Health Perspect. 101:386–387. 1995. View Article : Google Scholar : PubMed/NCBI
8	Taylor P: Anticholinesterase agents. The Pharmacological Basis of Therapeutics. Goodman Gilman A, Rall TW, Nies AS and Taylor P: Pergamon Press Inc; New York, NY: pp. 131–147. 1990
9	Klaasen C: Nonmetallic environmental toxicants: air pollutants, solvents and vapors, and pesticides. The Pharmacological Basis of Therapeutics. Goodman Gilman A, Rall TW, Nies AS and Taylor P: Pergamon Press Inc; New York, NY: pp. 1615–1635. 1990
10	Silman I and Futerman A: Modes of attachment of acetylcholinesterase to the surface membrane. Eur J Biochem. 170:11–20. 1987. View Article : Google Scholar : PubMed/NCBI
11	Krieger N: Rising incidence of breast cancer. J Natl Cancer Inst. 80:2–3. 1988. View Article : Google Scholar
12	Krieger N: Exposure, susceptibility, and breast cancer risk: a hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence. Breast Cancer Res Treat. 13:205–223. 1989. View Article : Google Scholar
13	Kelsey JL, Gammon MD and John EM: Reproductive factors and breast cancer. Epidemiol Rev. 15:36–47. 1993.PubMed/NCBI
14	Kelsey JL and Bernstein L: Epidemiology and prevention of breast cancer. Annu Rev Public Health. 17:47–67. 1996. View Article : Google Scholar : PubMed/NCBI
15	Lippman M, Bolan G and Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 36:4595–4601. 1976.PubMed/NCBI
16	Dickson RB and Lippman ME: Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer Treat Res. 40:119–165. 1988. View Article : Google Scholar : PubMed/NCBI
17	Key TJ and Pike MC: The dose-effect relationship between ‘unopposed’ oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer. 57:205–212. 1988.
18	Feigelson HS and Henderson BE: Estrogens and breast cancer. Carcinogenesis. 17:2279–2284. 1996. View Article : Google Scholar : PubMed/NCBI
19	Bernstein L: The epidemiology of breast cancer. LOWAC J. 1:7–13. 1998.
20	Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al: A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 87:190–197. 1995. View Article : Google Scholar : PubMed/NCBI
21	Adlercreutz H, Gorbach SL, Goldin BR, et al: Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst. 86:1076–1082. 1994. View Article : Google Scholar : PubMed/NCBI
22	Berrino F, Muti P, Micheli A, et al: Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 88:291–296. 1996. View Article : Google Scholar : PubMed/NCBI
23	Shimizu H, Ross RK, Bernstein L, et al: Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer. 62:451–453. 1990. View Article : Google Scholar : PubMed/NCBI
24	Bernstein L, Yuan JM, Ross RK, et al: Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control. 1:51–58. 1990. View Article : Google Scholar
25	Bernstein L, Ross RK, Pike MC, et al: Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer. 61:298–302. 1990. View Article : Google Scholar : PubMed/NCBI
26	Kirkman H: Estrogen-induced tumors of the kidney. III Growth characteristics in the Syrian hamster. Natl Cancer Inst Monogr. 1:1–57. 1959.PubMed/NCBI
27	Li JJ, Li SA, Klicka JK, et al: Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res. 43:5200–5204. 1983.PubMed/NCBI
28	International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 21. Scientific Publications, IARC; Lyon: pp. 279–362. 1979
29	International Agency for Research on Cancer (IARC). IARC Monographs on the Evolution of Carcinogenic Risks to Humans. IARC; (Suppl 7)Lyon: pp. 280–285. 1987
30	Cavalieri EL, Stack DE, Devanesan PD, et al: Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA. 94:10937–10942. 1997. View Article : Google Scholar : PubMed/NCBI
31	Chakravarti D, Mailander P, Cavalieri E, et al: Estrogen-DNA damage in mouse skin H-ras gene is mutated by error prone repair. Proc Am Assoc Cancer Res. 41:1072000.
32	Segaloff A and Maxfield WS: The synergism between radiation and estrogen in the production of mammary cancer in the rat. Cancer Res. 31:166–168. 1971.PubMed/NCBI
33	Calaf GM and Garrido F: Catechol estrogens as biomarkers for mammary gland cancer. Int J Oncol. 39:177–183. 2011.PubMed/NCBI
34	International Agency for Research on Cancer (IARC). IARC Monographs on the Evolution of Carcinogenic Risks to Humans. 72. Hormonal Contraception and Postmenopausal Hormone Therapy. IARC; Lyon: 1999
35	Huseby RA: Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse. Cancer Res. 40:1006–1013. 1980.PubMed/NCBI
36	Highman B, Norwell MJ and Shellenberger TE: Pathological changes in female C3H mice continuously fed diets containing diethylstilbestrol or 17beta-estradiol. J Environ Pathol Toxicol. 1:1–30. 1978.
37	Highman B, Greenman DL, Norvell MJ, Farmer J and Shellenberger TE: Neoplastic and preneoplastic lesions induced in female C3H mice by diets containing diethylstilbestrol or 17beta-estradiol. J Environ Pathol Toxicol. 4:81–95. 1980.
38	Highman B, Roth SI and Greenman DL: Osseous changes and osteosacomas in mice continuously fed diets containing diethylstilbestrol or 17beta-estradiol. J Natl Cancer Inst. 67:653–662. 1981.PubMed/NCBI
39	Nagasawa H, Mori T and Nakajima Y: Long-term effects of progesterone or diethylstilbestrol with or without estrogen after maturity on mammary tumorigenesis in mice. Eur J Cancer. 16:1583–1589. 1980. View Article : Google Scholar : PubMed/NCBI
40	Inoh A, Kamiya K, Fujii Y and Yokoro K: Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats. Jpn J Cancer Res. 76:699–704. 1985.PubMed/NCBI
41	Noble RL, Hochachka BC and King D: Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. Cancer Res. 35:766–780. 1975.PubMed/NCBI
42	Shull JD, Spady TJ, Snyder MC, Johansson SL and Pennington KL: Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. Carcinogenesis. 18:1595–1601. 1997. View Article : Google Scholar : PubMed/NCBI
43	Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 45:3415–3443. 1985.PubMed/NCBI
44	Li JJ and Li SA: Estrogen-induced tumorigenesis in hamsters: roles for hormonal and carcinogenic activities. Arch Toxicol. 55:110–118. 1984. View Article : Google Scholar : PubMed/NCBI
45	Li JJ and Li SA: Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc. 46:1858–1863. 1987.PubMed/NCBI
46	Bhat HK, Calaf GM, Hei TK, et al: Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA. 100:3913–3918. 2003. View Article : Google Scholar : PubMed/NCBI
47	Liehr JG: Genotoxic effects of estrogens. Mutat Res. 238:269–276. 1990. View Article : Google Scholar : PubMed/NCBI
48	Institute of Animal Laboratory Resources. Guide for the Care and Use of Laboratory Animals. National Academy Press; Washington, DC: 1996
49	Russo J and Russo IH: Mammary tumorigenesis. Prog Exp Tumor Res. 33:175–191. 1991.
50	Wellings SR, Jensen HM and Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 55:231–273. 1975.PubMed/NCBI
51	Cabello G, Valenzuela M, Vilaxa A, et al: A rat mammary tumor model induced by the organophosphorous pesticides parathion and malathion, possibly through acetylcholinesterase inhibition. Environ Health Perspect. 109:471–479. 2001. View Article : Google Scholar
52	Alfaro-Lira S, Pizarro-Ortiz M and Calaf GM: Malignant transformation of rat kidney induced by environmental substances and estrogen. Int J Environ Res Public Health. (In Press).
53	Echiburu-Chau C and Calaf GM: Rat lung cancer induced by malathion and estrogen. Int J Oncol. 33:603–611. 2008.PubMed/NCBI